Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 72 Records) |
| Query Trace: Breast Neoplasms and MSH2[original query] |
|---|
| Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer. Cancers 2020 Oct 12 (10): . Pavanello Marina, Chan Isaac Hy, Ariff Amir, Pharoah Paul Dp, Gayther Simon A, Ramus Susan |
| Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. Cancers 2021 Jun 13 (12): . Li Wenjing, Amei Amei, Bui Francis, Norouzifar Saba, Lu Lingeng, Wang Zuohe |
| Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC medical genomics 2021 7 14 (1): 185. Winham Stacey J, Wang Chen, Heinzen Ethan P, Bhagwate Aditya, Liu Yuanhang, McDonough Samantha J, Stallings-Mann Melody L, Frost Marlene H, Vierkant Robert A, Denison Lori A, Carter Jodi M, Sherman Mark E, Radisky Derek C, Degnim Amy C, Cunningham Julie |
| Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer. Human mutation 2021 7 42 (10): 1265-1278. Johnatty Sharon E, Pesaran Tina, Dolinsky Jill, Yussuf Amal, LaDuca Holly, James Paul A, O'Mara Tracy A, Spurdle Amanda |
| Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer. Clinical breast cancer 2021 5 21 (6): e647-e653. Ece Solmaz Asl?, Yeniay Levent, Gökmen Erhan, Zekio?lu Osman, Haydaro?lu Ayfer, Bilgen I??l, Özk?nay Ferda, Onay Hüsey |
| Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients. Oncotarget 2021 Mar 12 (7): 686-697. Barakeh Duna H, Aljelaify Rasha, Bashawri Yara, Almutairi Amal, Alqubaishi Fatimah, Alnamnakani Mohammed, Almubarak Latifa, Al Naeem Abdulrahman, Almushawah Fatema, Alrashed May, Abedalthagafi Mal |
| Lapses in breast cancer screening for highly penetrant mutation carriers during pregnancy and lactation. Journal of surgical oncology 2021 Dec . Chichura Anna, Hunt Jonathan, Lang Julie, Pederson Hol |
| [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 10 43 (10): 1088-1093. Tang X J, Yang M Y, Zhu L Z, Xu D, Yuan |
| Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 10 28 (2): 404-413. Schwartz Christopher J, da Silva Edaise M, Marra Antonio, Gazzo Andrea M, Selenica Pier, Rai Vikas K, Mandelker Diana, Pareja Fresia, Misyura Maksym, D'Alfonso Timothy M, Brogi Edi, Drullinsky Pamela, Razavi Pedram, Robson Mark E, Drago Joshua Z, Wen Hannah Y, Zhang Liying, Weigelt Britta, Shia Jinru, Reis-Filho Jorge S, Zhang Ho |
| Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes. JNCI cancer spectrum 2021 1 5 (1): . Kurian Allison W, Ward Kevin C, Abrahamse Paul, Hamilton Ann S, Katz Steven |
| Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes. Molecular biology reports 2022 9 49 (11): 10293-10305. Bhattacharya Priyanjali, Patel Trupti |
| Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. Asian Pacific journal of cancer prevention : APJCP 2022 6 23 (6): 2027-2033. Gervas Polina, Molokov Aleksey, Babyshkina Nataliya, Kiselev Artem, Zarubin Aleksei, Yumov Evgeny, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
| The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis. Cancer medicine 2022 Jun . Adolf Ismael C, Rweyemamu Linus P, Akan Gokce, Mselle Ted F, Dharsee Nazima, Namkinga Lucy A, Lyantagaye Sylvester L, Atalar Fatmah |
| Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. JCO precision oncology 2022 2 1 1-12. Kurian Allison W, Hughes Elisha, Handorf Elizabeth A, Gutin Alexander, Allen Brian, Hartman Anne-Renee, Hall Michael |
| Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer. Journal of Cancer 2022 2 13 (3): 869-876. Park Song Ee, Kim Hee Sung, Jung Eun-Jung, Suh Ja Hee, Min Hyeyoung, Chi Kyong-Choun, Kim Jong Won, Park Joong-Min, Hwang In G |
| The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021. Frontiers in genetics 2022 11 13 1020543. Roht Laura, Tooming Mikk, Rekker Kadri, Roomere Hanno, Toome Kadri, Murumets Ülle, Šamarina Ustina, Õunap Katrin, Kahre Tii |
| No Evidence of Increased Risk of Breast Cancer in Women With Lynch Syndrome Identified by Multigene Panel Testing. JCO precision oncology 2022 1 4 51-60. Stoll Jessica, Rosenthal Eric, Cummings Shelly, Willmott Jamie, Bernhisel Ryan, Kupfer Sonia |
| Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling. Mutation research 2023 7 827 111831. Zeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzo?lu, Mutlu Do?an, Öztürk Ate?, Ece Esin, ?rem Bilgetekin, Umut Demirci, Ça?lar Köseo?lu, Alper Topal, Nuri Karadurmu?, Haktan Ba??? Erdem, Taha Bah |
| Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
| Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. JAMA oncology 2023 5 . Xuan Chen, Margaret A Meyer, Jennifer L Kemppainen, Masayasu Horibe, Shruti Chandra, Shounak Majumder, Gloria M Petersen, Kari G Ra |
| Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis. Molecular oncology 2023 4 . Sun Zhe, Bai Chujie, Su Miaoyi, Tang Haimeng, Wu Xiaoying, Wang Yue, Bao Hua, Liu Xunbiao, Wu Xue, Shao Yang, Xu B |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Frontiers in genetics 2023 2 14 1094260. Díaz-Velásquez Clara Estela, Gitler Rina, Antoniano Adriana, Kershenovich Sefchovich Ronny, De La Cruz-Montoya Aldo Hugo, Martínez-Gregorio Héctor, Rojas-Jiménez Ernesto Arturo, Cortez Cardoso Penha Ricardo, Terrazas Luis Ignacio, Wegman-Ostrosky Talia, Levi-Lahad Ephrat, Zabaleta Jovanny, Perdomo Sandra, Vaca-Paniagua Feli |
| Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 2023 2 4 (2): 156-163. Mian Abrar, Wei Jun, Shi Zhuqing, Rifkin Andrew S, Zheng S Lilly, Glaser Alexander P, Kearns James T, Helfand Brian T, Xu Jianfe |
| Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
| Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human genomics 2023 1 17 (1): 2. Kim Jinyong, Jeong Kyeonghun, Jun Hyeji, Kim Kwangsoo, Bae Jeong Mo, Song Myung Geun, Yi Hanbaek, Park Songyi, Woo Go-Un, Lee Dae-Won, Kim Tae-Yong, Lee Kyung-Hun, Im Seock- |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Genes 2023 1 14 (1): . Nassar Auhood, Zekri Abdel-Rahman N, Kamel Mahmoud M, Elberry Mostafa H, Lotfy Mai M, Seadawy Mohamed G, Hassan Zeinab K, Soliman Hany K, Lymona Ahmed M, Youssef Amira Salah El-D |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. NPJ precision oncology 2024 6 8 (1): 136. Miguel Ruiz-De La Cruz, Héctor Martínez-Gregorio, Clara Estela Díaz-Velásquez, Fernando Ambriz-Barrera, Norma Gabriela Resendiz-Flores, Rina Gitler-Weingarten, María Patricia Rojo-Castillo, Didier Pradda, Javier Oliver, Sandra Perdomo, Eva María Gómez-García, Aldo Hugo De La Cruz-Montoya, Luis Ignacio Terrazas, Gabriela Torres-Mejía, Fidel de la Cruz Hernández-Hernández, Felipe Vaca-Paniag |
| Comparative sequencing study of mismatch repair and homology-directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan. International journal of cancer 2024 10 . Ying Zheng, Natalia Vdovichenko, Peter Schürmann, Dhanya Ramachandran, Robert Geffers, Lisa-Marie Speith, Natalia Bogdanova, Julia Enßen, Natalia Dubrowinskaja, Tatyana Yugay, Zura Berkutovna Yessimsiitova, Nurzhan Turmanov, Peter Hillemanns, Thilo Dö |
- Page last reviewed:Feb 1, 2024
- Content source: